Abstract No. 575 Safety and Success of Transjugular Liver Biopsies in Children: A Single Tertiary Care Center Experience

Autor: Kerwin, C., Shin, J., Zapala, M., Courtier, J., Kolli, K., Durand, R.

Publikováno v: In Journal of Vascular and Interventional Radiology March 2023 34(3) Supplement:S163-S163

Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease

Autor: Harlow, KE, Africa, JA, Wells, A, Belt, PH, Behling, CA, Jain, AK, Molleston, JP, Newton, KP, Rosenthal, P, Vos, MB, Xanthakos, SA, Lavine, JE, Schwimmer, JB, Abrams, SH, Barlow, S, Himes, R, Krisnamurthy, R, Maldonado, L, Mahabir, R, Carr, A, Bernstein, K, Bramlage, K, Cecil, K, DeVore, S, Kohli, R, Lake, K, Podberesky, D, Towbin, A, Behr, G, Lefkowitch, JH, Mencin, A, Reynoso, E, Alazraki, A, Cleeton, R, Cordero, M, Hernandez, A, Karpen, S, Munos, JC, Raviele, N, Bozic, M, Cummings, OW, Klipsch, A, Ragozzino, E, Sandrasegaran, K, Subbarao, G, Walker, L, Kafka, K, Scheimann, A, Ito, J, Fishbein, MH, Mohammad, S, Rigsby, C, Sharda, L, Whitington, PF, Cattoor, T, Derdoy, J, Freebersyser, J, King, D, Lai, J, Osmack, P, Siegner, J, Stewart, S, Torretta, S, Wriston, K, Baker, SS, Lopez-Graham, D, Williams, S, Zhu, L, Awai, H, Bross, C, Collins, J, Durelle, J, Middleton, M, Paiz, M, Sirlin, C, Ugalde-Nicalo, P, Villarreal, MD, Aouizerat, B, Courtier, J, Ferrell, LD, Feier, N, Gill, R, Langlois, C, Perito, ER, Tsai, P, Cooper, K, Horslen, S, Hsu, E, Murray, K, Otto, R, Yeh, M, Young, M, Brunt, EM, Fowler, K

Publikováno v: Harlow, KE; Africa, JA; Wells, A; Belt, PH; Behling, CA; Jain, AK; et al.(2018). Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease. Journal of Pediatrics, 198, 76-83.e2. doi: 10.1016/j.jpeds.2018.02.038. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/2386g6hb

© 2018 Elsevier Inc. Objective: To determine the percentage of children with nonalcoholic fatty liver disease (NAFLD) in whom intervention for low-density lipoprotein cholesterol or triglycerides was indicated based on National Heart, Lung, and Bloo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::ffa40065e58a3bc88611368ea48fc9e6
http://www.escholarship.org/uc/item/2386g6hb

In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores

Autor: Schwimmer, JB, Lavine, JE, Wilson, LA, Neuschwander-Tetri, BA, Xanthakos, SA, Kohli, R, Barlow, SE, Vos, MB, Karpen, SJ, Molleston, JP, Whitington, PF, Rosenthal, P, Jain, AK, Murray, KF, Brunt, EM, Kleiner, DE, Van Natta, ML, Clark, JM, Tonascia, J, Doo, E, Abrams, SH, Barlow, S, Himes, R, Krisnamurthy, R, Maldonado, L, Mahabir, R, Bernstein, K, Bramlage, K, Cecil, K, DeVore, S, Lake, K, Podberesky, D, Towbin, A, Xanthakos, S, Behr, G, Lefkowitch, JH, Mencin, A, Reynoso, E, Alazraki, A, Cleeton, R, Karpen, S, Cruz Munos, J, Raviele, N, Vos, M, Bozic, M, Cummings, OW, Klipsch, A, Munson, S, Sandrasegaran, K, Subbarao, G, Kafka, K, Scheimann, A, Amsden, K, Fishbein, MH, Kirwan, E, Mohammad, S, Rigsby, C, Sharda, L, Derdoy, J, Jain, A, King, D, Osmack, P, Siegner, J, Stewart, S, Torretta, S, Wriston, K, Baker, SS, Zhu, L, Africa, J, Angeles, J, Arroyo, S, Awai, H, Behling, C, Bross, C, Durelle, J, Middleton, M, Newton, K, Paiz, M, Sanford, J, Sirlin, C, Ugalde-Nicalo, P, Villarreal, MD, Aouizerat, B, Courtier, J, Ferrell, LD, Fleck, S, Gill, R

Publikováno v: Schwimmer, JB; Lavine, JE; Wilson, LA; Neuschwander-Tetri, BA; Xanthakos, SA; Kohli, R; et al.(2016). In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores. Gastroenterology, 151(6), 1141-1154.e9. doi: 10.1053/j.gastro.2016.08.027. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/2h61w9m6

© 2016 AGA Institute Background & Aims No treatment for nonalcoholic fatty liver disease (NAFLD) has been approved by regulatory agencies. We performed a randomized controlled trial to determine whether 52 weeks of cysteamine bitartrate delayed rele

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::8f8d76d030f47341a123c9106929dba2
http://www.escholarship.org/uc/item/2h61w9m6

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Primary mixed malignant tumor of bone in an 18-year-old male: Report of a case with radiologic-pathologic correlation

Autor: Mackenzie, John, Courtier, J, Robbins, E, Soares, B, Horvai, A, MacKenzie, JD

Publikováno v: Mackenzie, John; Courtier, J; Robbins, E; Soares, B; Horvai, A; & MacKenzie, JD. (2012). Primary mixed malignant tumor of bone in an 18-year-old male: Report of a case with radiologic-pathologic correlation. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/22n6d8r6

We report a case of primary malignant mixed tumor (MMT) of bone in an 18-year-old boy with X-ray, CT, MR, scintigraphic, FDG PET, and pathologic correlation. Primary MMT of bone is a highly aggressive tumor and presents both a diagnostic and clinical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::147b22880a62b4ced7a6fc6e56a4fbcc
http://www.escholarship.org/uc/item/22n6d8r6